Understanding the impact of chemotherapy on dignity for older people and their partners.

Eur J Oncol Nurs

The Christie NHS Trust, Wilmslow Road, Withington, Manchester, M20 4BX, England, UK. Electronic address:

Published: October 2018

Purpose: Chemotherapy poses challenges for older patients, with potential comorbidities, mobility and functional problems that may adversely affect their dignity. Patients may struggle with side-effects but fail to inform health professionals, impacting on clinical management and unresolved needs/concerns. This study aims to explore the impact of dignity during chemotherapy for older people and partners.

Methods: A qualitative study using semi-structured interviews of patients/partners following chemotherapy for non-metastatic cancer. Interviews were audio-recorded, transcribed and analysed using qualitative principles/thematic analysis.

Results: Twenty patients, aged 65-81, and 10 partners were recruited. 19/20 patients had adjuvant chemotherapy and one neoadjuvant treatment; 12(60%) had breast cancer and 8(40%) colorectal cancer. Four out of 20(20%) patients failed to complete the full course of chemotherapy and 5(25%) had unplanned hospital admissions. Patients/partners reported positive experiences regarding dignity and compassionate care during chemotherapy. Five main themes were associated with dignity: managing chemotherapy side-effects, personal feelings, maintaining independence, stoicism, and 'being lucky'. Although support from family/friends was high, most patients wanted to maintain their independence and did not want to become a burden. In some cases, patients struggled with chemotherapy toxicities yet often failed to inform clinical staff and played down the severity of adverse effects. This reflected their stoicism, coping strategies and motivations to 'just get on with it'.

Conclusions: Dignity is associated with maintaining independence and stoicism in coping with the impact of chemotherapy. However, some patients failed to report severe adverse effects, which has implications for clinical staff managing their care.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejon.2018.05.008DOI Listing

Publication Analysis

Top Keywords

chemotherapy
10
impact chemotherapy
8
older people
8
patients
8
patients failed
8
maintaining independence
8
independence stoicism
8
clinical staff
8
adverse effects
8
stoicism coping
8

Similar Publications

Quantification of ivermectin in veterinary products consumed off-label as a treatment for COVID-19.

Pharmazie

December 2024

Centre of Excellence for Pharmaceutical Sciences (Pharmacen™), North-West University, Potchefstroom, Republic of South Africa.

The COVID-19 pandemic caused global pandemonium, and due to an unprecedented global response, the popularity and use of (veterinary) ivermectin, amongst many other conceivable 'treatments', experienced a meteoric rise. Ivermectin is a macrocyclic lactone compound belonging to the avermectin drug class and is a registered medicine in many countries, although the most common use is as veterinary medicine. In this study, a fast HPLC method was developed and validated for the quantification of ivermectin in veterinary products that were used off-label by a substantial number of people during COVID-19.

View Article and Find Full Text PDF

Background: Tumor size (TS) in pancreatic ductal adenocarcinoma (PDAC) is one of the most important prognostic factors. However, discrepancies between TS on preoperative images (TSi) and pathological specimens (TSp) have been reported. This study aims to evaluate the factors associated with the differences between TSi and TSp.

View Article and Find Full Text PDF

Background: As the population ages, the number of octogenarians with pancreatic ductal adenocarcinoma (PDAC) continues to rise. Morbidity and mortality following pancreatectomy have improved owing to safer surgery and better chemoradiation regimens. This study compares the outcomes and multimodality utilization in octogenarians (≥80 years) who underwent pancreaticoduodenectomy (PD) for PDAC, with a younger cohort.

View Article and Find Full Text PDF

Background And Objective: Limited information is available on the pharmacokinetics of rifampicin (RIF) along with that of its active metabolite, 25-deacetylrifampicin (25-dRIF). This study aimed to analyse the pharmacokinetic data of RIF and 25-dRIF collected in adult patients treated for tuberculosis.

Methods: In adult patients receiving 10 mg/kg of RIF as part of a standard regimen for drug-susceptible pulmonary tuberculosis enrolled in the Opti-4TB study, plasma RIF and 25-dRIF concentrations were measured at various occasions.

View Article and Find Full Text PDF

Prognostic factors for overall survival in castration-resistant metastatic prostate cancer treated with docetaxel (MeProCSS): results from a German real-world cohort.

Int Urol Nephrol

January 2025

Department of Urology and Urosurgery, Medical Faculty Mannheim, University Medical Centre Mannheim (UMM), University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Baden-Württemberg, Germany.

Purpose: To identify prognostic factors for overall survival (OS) and develop a prognostic score in patients receiving docetaxel in metastatic castration-resistant prostate cancer (mCRPC).

Methods: Retrospective analysis was conducted on mCRPC patients treated with docetaxel at a German tertiary center between March 2010 and November 2023. Prognostic clinical and laboratory factors were analyzed using uni- and multivariable logistic regression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!